Rizatriptan

Rizatriptan is a medication used for the treatment of migraine headaches. It is administrated orally or can be applied on the tongue. It works by narrowing the blood vessels in the brain leading to blocking the pain signals. In 1991, Rizatriptan was patented and came into medical use in 1998. It is also available as generic medicine.

Various Rizatriptan related compounds or reference standards, listed on this page are needed in pharmaceutical research at the time to product development, ANDA filing or during production to study quality, stability, and genotoxicity study of Rizatriptan related products.

SynThink is a most trusted source of Rizatriptan degradation impurities, genotoxic impurities, process related impurities, EP / USP related compounds and nitrosamine impurities. All the products are are thoroughly characterized and re-tested at regular intervals. Rizatriptan products are supplied with detailed COA & analytical data as per the regulatory compliance.